Valent BioSciences Partners with Vita Bee Health to Develop New Biological Wax Moth Control That Safeguards Health of Honeybees

FOR IMMEDIATE RELEASE

Valent BioSciences Partners with Vita Bee Health to Develop New Biological Wax Moth Control That Safeguards Health of Honeybees

LIBERTYVILLE, Ill., June 16, 2020 – Two global leaders are expanding their longtime collaborative partnership by launching a new biological wax moth control product that helps safeguard the health of honeybees. Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, and Vita Bee Health, the world’s largest dedicated supplier of honeybee health products, have joined together to develop B402 (also known as Certan), an advanced and effective solution that protects honeycombs from wax-eating caterpillars.

The new product utilizes a concentrated solution of Bacillus thuringiensis (Bt), a bacterium commonly found in nature that selectively kills wax moths at the larval stage. These moths, which can destroy honeybee wax combs and even the structure of hives, cause widespread damage and even colony losses for beekeepers. B402 offers efficacy of up to 100 percent against wax moth larvae.

“Bt is a commonly used biological control for many agricultural pests,” said Dr. Max Watkins, CEO of Vita Bee Health. “Together with Valent Biosciences, we faced the challenge of finding a strain that selectively targets wax moths. We sought to improve on B401, an earlier bee-safe product. Our synergistic relationship with Valent Biosciences, combined with the company’s quality control and product consistency, enabled us to work together successfully to locate a strain and formulation of Bt that demonstrates specific control of both greater and lesser wax moths (Galleria mellonella and Achroia grisella), while being harmless to bees under this use. Valent BioSciences continues to be extremely supportive in helping us innovate for the benefit of beekeepers.”

Regina Rieckenberg, Vice President of Global Marketing and Business Management for Valent BioSciences, said, “We have worked closely with Vita Bee Health for years and, as a result, have developed valuable knowledge and insights about the honeybee industry. With our extensive expertise in biological products, we were able to team with Vita Bee Health to create this innovative new formulation offering a variety of unmatched benefits.”

Recently approved for use with honeybee colonies by the U.S. Environmental Protection Agency (EPA), B402 is safe to use and harmless to beneficial insects and pollinators. It leaves no chemical residues in wax or honey, and only a single application is necessary to provide complete protection.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Vita Bee Health

Vita Bee Health, a trading name of Vita (Europe) Ltd., is a mite control and honeybee health specialist. It is the world’s largest dedicated supplier of honeybee health products to the honey and pollination industries. With a rigorous and ethical approach to research and development into honeybee health, Vita has no commercial interests in crop pesticides or crop breeding that may be harmful to honeybees.

Vita promotes sustainable beekeeping through Integrated Pest Management (IPM). Its treatments are designed to inhibit the build-up of resistance and wherever possible contain natural compounds and biological controls that are benign to all but the target pests. For more information, visit the company’s website at www.vitabeehealth.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728

Email: john.mandel@valentbiosciences.com

Download News Release